Streptomyces coeruleorubidus

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Streptomyces coeruleorubidus
Scientific classification Edit this classification
Domain: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Streptomycetales
Family: Streptomycetaceae
Genus: Streptomyces
Species:
S. coeruleorubidus
Binomial name
Streptomyces coeruleorubidus
(Preobrazhenskaya 1957) Pridham et al. 1958 (Approved Lists 1980)[1]
Type strain
AS 4.1678, ATCC 13740, ATCC 23900, BCRC 11463, CBS 796.68, CCRC 11463, CGMCC 4.1678, DSM 40145, ETH 24205, Gause12531/54, IFO 12855, IMET 42060, INA 12531/54, ISP 5145, JCM 4359, KCC S-0359, KCCS-0359, KCTC 1743, KCTC 1922, NBIMCC 1152, NBRC 12855, NCIB 9620, NCIMB 9620, NCIMB 9833, NRRL B-2569, NRRL-ISP 5145, PSA 181, RIA 1132, VKM Ac-576, Waksman 3840
Synonyms
  • "Actinomyces coeruleorubidus" Preobrazhenskaya 1957

Streptomyces coeruleorubidus is a bacterium species from the genus of Streptomyces which has been isolated from marine sediment.[1][2] Streptomyces coeruleorubidus produces the following medications: pacidamycin 1, baumycin B1, baumycin B2, baumycin C1, feudomycin A, feudomycin B, feudomycin C, ficellomycin, feudomycinone A, and rubomycin.[2][3][4][5][6][7][8][9]

Further reading

  • Kandula, Siva Kumar; Terli, Ramana (May 2013). "Production, purification and characterization of an antimicrobial compound from marine Streptomyces coeruleorubidus BTSS-301". Journal of Pharmacy Research. 7 (5): 397–403. doi:10.1016/j.jopr.2013.04.047.
  • Yoshimoto, A; Oki, T; Takeuchi, T; Umezawa, H (October 1980). "Microbial conversion of anthracyclinones to daunomycin by blocked mutants of Streptomyces coeruleorubidus". The Journal of Antibiotics. 33 (10): 1158–66. doi:10.7164/antibiotics.33.1158. PMID 7451367.
  • Fronko, RM; Lee, JC; Galazzo, JG; Chamberland, S; Malouin, F; Lee, MD (December 2000). "New pacidamycins produced by Streptomyces coeruleorubidus, NRRL 18370". The Journal of Antibiotics. 53 (12): 1405–10. doi:10.7164/antibiotics.53.1405. PMID 11217807.
  • Shang, Ke; Hu, Youjia; Zhu, Chunbao; Zhu, Baoquan (22 November 2007). "Production of 4'-epidaunorubicin by metabolic engineering of Streptomyces coeruleorubidus strain SIPI-1482". World Journal of Microbiology and Biotechnology. 24 (7): 1107–1113. doi:10.1007/s11274-007-9610-5. S2CID 84366644.
  • Blumauerová, M; Královcová, E; Matĕjů, J; Jizba, J; Vanĕk, Z (1979). "Biotransformations of anthracyclinones in Streptomyces coeruleorubidus and Streptomyces galilaeus". Folia Microbiologica. 24 (2): 117–27. doi:10.1007/bf02927295. PMID 456946. S2CID 7878810.
  • Oki, T; Matsuzawa, Y; Kiyoshima, K; Yoshimoto, A; Naganawa, H; Takeuchi, T; Umezawa, H (July 1981). "New anthracyclines, feudomycins, produced by the mutant from Streptomyces coeruleorubidus ME130-A4". The Journal of Antibiotics. 34 (7): 783–90. doi:10.7164/antibiotics.34.783. PMID 7287580.
  • ed.-in-chief, George M. Garrity (2012). Bergey's manual of systematic bacteriology (2nd ed.). New York: Springer Science + Business Media. ISBN 978-0-387-68233-4. {{cite book}}: |last1= has generic name (help)
  • H., Kersten; W., Kersten (1974). Inhibitors of Nucleic Acid Synthesis Biophysical and Biochemical Aspects. Molecular Biology, Biochemistry, and Biophysics. Berlin, Heidelberg: Springer Berlin Heidelberg. pp. 1–184. doi:10.1007/978-3-642-80855-5. ISBN 3-642-80855-7. PMID 4143460. S2CID 37777287.
  • Ravina, Enrique (2011). The evolution of drug discovery : from traditional medicines to modern drugs (1. Aufl. ed.). Weinheim: Wiley-VCH. ISBN 978-3-527-32669-3.
  • Knölker, edited by Hans-Joachim (2012). The Alkaloids (1st ed.). Burlington: Elsevier Science. ISBN 978-0-12-397758-8. {{cite book}}: |first1= has generic name (help)

See also

References

  1. ^ a b LPSN bacterio.net
  2. ^ a b Deutsche Sammlung von Mikroorganismen und Zellkulturen [1]
  3. ^ Oki, T; Matsuzawa, Y; Kiyoshima, K; Yoshimoto, A; Naganawa, H; Takeuchi, T; Umezawa, H (July 1981). "New anthracyclines, feudomycins, produced by the mutant from Streptomyces coeruleorubidus ME130-A4". The Journal of Antibiotics. 34 (7): 783–90. doi:10.7164/antibiotics.34.783. PMID 7287580.
  4. ^ Collins, Peter M., ed. (2006). Dictionary of carbohydrates with CD-ROM (2nd ed.). Boca Raton: CRC/Taylor & Francis. ISBN 0-8493-7765-X.
  5. ^ Roberts, edited by B.W. Bycroft ; contributors, A.A. Higton, A.D. (1988). Dictionary of antibiotics and related substances. London: Chapman and Hall. ISBN 0-412-25450-6. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link)
  6. ^ R., Hänsel (1980). Pharmazeutische Biologie Spezieller Teil. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-642-67591-3.
  7. ^ al.], J.M. Lackie [editor] ; authors contributing to earlier editions, S.E. Blackshaw ... [et (2007). The dictionary of cell and molecular biology (4th ed.). Amsterdam: Elsevier. ISBN 978-0-08-055034-3. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link)
  8. ^ Gennilloud, Edited by Olga; Vicente, Francisca (2012). Drug discovery from microbial natural products. Cambridge: Royal Society of Chemistry. ISBN 978-1-84973-361-8. {{cite book}}: |first1= has generic name (help)
  9. ^ RS, Satoskar; Nirmala, Rege; SD, Bhandarkar (2015). Pharmacology and Pharmacotherapeutics. Elsevier Health Sciences. ISBN 978-81-312-4371-8.

External links